论文信息 - Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. - 字舞流文

Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.

J. Kremer | V. Strand | M. Weisman | M. Genovese | D. Furst | E. Keystone | A. Kavanaugh | E. Ruderman | J. Cush | J. Bathon | J. Markenson | M. Luggen | J. Caldwell | B. Crawford | G. Cannon | P. Coleman | David Curtis | E. Kopp | S. Kantor | J. Waltuck | H. Lindsley | I. Fernando | K. Simpson